Ozempic May Blunt Metabolic Effects of Antipsychotics

(MedPage Today) — A GLP-1 receptor agonist may help improve metabolic profiles for certain schizophrenia patients on antipsychotics, the randomized HISTORI trial indicated.
Among 154 schizophrenia patients with prediabetes and overweight or obesity…

Source link : https://www.medpagetoday.com/psychiatry/schizophrenia/117292

Author :

Publish date : 2025-09-03 18:49:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Ozempic May Blunt Metabolic Effects of Antipsychotics

ADHD Meds and Psychosis; RFK Jr. Targets SSRIs; 1B People Have Psych Disorders

Plant-based dog foods provide almost all the nutrients pets need

Related Posts

More Evidence for Lower Ribociclib Dose in Advanced Breast Cancer

Docs Decry Tylenol Claims; Unsung Healthcare Heroes; ‘I Study, Then Study, Then …’

Nutrition Therapy for Weight Loss: What Works, What Doesn’t

Connecticut Settles Lawsuit Over Killing of Visiting Nurse for $2 Million

FDA Tosses REMS Restriction on Thyroid Cancer Drug

Novel Drug Shows Hints of Promise for Progressive MS

More Evidence for Lower Ribociclib Dose in Advanced Breast Cancer

Docs Decry Tylenol Claims; Unsung Healthcare Heroes; ‘I Study, Then Study, Then …’

Nutrition Therapy for Weight Loss: What Works, What Doesn’t

Connecticut Settles Lawsuit Over Killing of Visiting Nurse for $2 Million

FDA Tosses REMS Restriction on Thyroid Cancer Drug

Novel Drug Shows Hints of Promise for Progressive MS

Federal Bill Would Free Up Visas to Ease Physician Shortage

Tylenol’s Tweet on Pregnancy Use Being Taken Out of Context, Experts Say

Categories

Archives